Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Recognizing and treating oral lichen sclerosus is important, but treatment guidelines are lacking.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Daughters with affected mothers may develop frontal fibrosing alopecia early.

Notch signaling disruptions can cause various skin diseases.

Suriname uses many plants for beauty, with potential for a beauty industry, but more evidence is needed for product effectiveness.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Upadacitinib improved multiple immune-related conditions in one patient.

If someone has scaly skin, muscle stiffness, and intellectual disability, doctors should consider Sjogren-Larsson Syndrome, but other conditions if more symptoms are present.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Children and adolescents with allergies tend to have longer eyelashes.

A 5-year-old boy's seasonal hair loss is linked to his allergies.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Children with atopic diseases have a higher risk of developing alopecia areata.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Alopecia areata greatly affects quality of life, with many experiencing mental health issues and lacking professional support.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health issues.

Alopecia areata may be linked to atopic diseases like eczema, asthma, and allergies.